Caribou Biosciences, Inc. (CRBU) Return on equity 2019–2025
Caribou Biosciences, Inc. (CRBU) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-121.2%FY2025 · since FY2019: -314.0% → -121.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -121.2% | -62.3 pp |
| FY2024 | -58.9% | -31.2 pp |
| FY2023 | -27.7% | +5.3 pp |
| FY2022 | -33.0% | -15.8 pp |
| FY2021 | -17.3% | — |
| FY2019 | -314.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice